Al­tos Labs buys an­ti-ag­ing start­up Do­ri­an Ther­a­peu­tics

Al­tos Labs, the mas­sive but still rel­a­tive­ly se­cre­tive $3 bil­lion biotech, has forged a small ac­qui­si­tion of a start­up seek­ing to re­verse ag­ing.

Al­tos, led …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER